Electra Therapeutics

ETRA · NASDAQ

$8.81+$0.20 (+2.32%)TodayMarket closed ·
Prev close $8.61

About ETRA

Electra Therapeutics, Inc. is a US-based company operating in Biotechnology industry. The company is headquartered in South San Francisco, California and currently employs 46 full-time employees. The company went IPO on 2026-09-18. Electra Therapeutics Inc is a United States-based clinical- stage biotechnology company. The firm is developing therapies that target signal regulatory proteins (SIRP) for the treatment of immunological diseases and cancer. Its ELA026, is a monoclonal antibody that targets SIRP on the cell surface of myeloid and T cells and precisely depletes pathological immune cells.

Employees
46
Headquarters
South San Francisco, California
Listed
Sep 18, 2026
Sector
Health Care
Industry
Biotechnology

Similar companies

Companies in the same industry as Electra Therapeutics

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.